These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19890354)

  • 1. In vitro and in vivo functional characterization of gutless recombinant SV40-derived CFTR vectors.
    Mueller C; Strayer MS; Sirninger J; Braag S; Branco F; Louboutin JP; Flotte TR; Strayer DS
    Gene Ther; 2010 Feb; 17(2):227-37. PubMed ID: 19890354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of CFTR by adenoviral vector to cystic fibrosis mouse lung in a model of chronic Pseudomonas aeruginosa lung infection.
    Van Heeckeren AM; Scaria A; Schluchter MD; Ferkol TW; Wadsworth S; Davis PB
    Am J Physiol Lung Cell Mol Physiol; 2004 Apr; 286(4):L717-26. PubMed ID: 14514520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus engineered to express the cystic fibrosis transmembrane conductance regulator corrects the bioelectric phenotype of human cystic fibrosis airway epithelium in vitro.
    Kwilas AR; Yednak MA; Zhang L; Liesman R; Collins PL; Pickles RJ; Peeples ME
    J Virol; 2010 Aug; 84(15):7770-81. PubMed ID: 20504917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of the proinflammatory state in cystic fibrosis lung epithelial cells by genes from the TNF-alphaR/NFkappaB pathway.
    Eidelman O; Srivastava M; Zhang J; Leighton X; Murtie J; Jozwik C; Jacobson K; Weinstein DL; Metcalf EL; Pollard HB
    Mol Med; 2001 Aug; 7(8):523-34. PubMed ID: 11591888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.
    Stotland PK; Radzioch D; Stevenson MM
    Pediatr Pulmonol; 2000 Nov; 30(5):413-24. PubMed ID: 11064433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis transmembrane conductance regulator dysfunction in platelets drives lung hyperinflammation.
    Ortiz-Muñoz G; Yu MA; Lefrançais E; Mallavia B; Valet C; Tian JJ; Ranucci S; Wang KM; Liu Z; Kwaan N; Dawson D; Kleinhenz ME; Khasawneh FT; Haggie PM; Verkman AS; Looney MR
    J Clin Invest; 2020 Apr; 130(4):2041-2053. PubMed ID: 31961827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sendai virus-mediated CFTR gene transfer to the airway epithelium.
    Ferrari S; Griesenbach U; Iida A; Farley R; Wright AM; Zhu J; Munkonge FM; Smith SN; You J; Ban H; Inoue M; Chan M; Singh C; Verdon B; Argent BE; Wainwright B; Jeffery PK; Geddes DM; Porteous DJ; Hyde SC; Gray MA; Hasegawa M; Alton EW
    Gene Ther; 2007 Oct; 14(19):1371-9. PubMed ID: 17597790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for the respiratory manifestations of cystic fibrosis.
    Korst RJ; McElvaney NG; Chu CS; Rosenfeld MA; Mastrangeli A; Hay J; Brody SL; Eissa NT; Danel C; Jaffe HA
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S75-87. PubMed ID: 7533609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice.
    Cmielewski P; Donnelley M; Parsons DW
    J Gene Med; 2014; 16(9-10):291-9. PubMed ID: 25130650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector.
    Sirninger J; Muller C; Braag S; Tang Q; Yue H; Detrisac C; Ferkol T; Guggino WB; Flotte TR
    Hum Gene Ther; 2004 Sep; 15(9):832-41. PubMed ID: 15353038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
    Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
    Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function.
    Zhang S; Shrestha CL; Kopp BT
    Sci Rep; 2018 Nov; 8(1):17066. PubMed ID: 30459435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
    Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
    Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel AAV-mediated Gene Delivery System Corrects CFTR Function in Pigs.
    Cooney AL; Thornell IM; Singh BK; Shah VS; Stoltz DA; McCray PB; Zabner J; Sinn PL
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):747-754. PubMed ID: 31184507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
    Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
    Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
    Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
    Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice.
    Davies LA; Varathalingam A; Painter H; Lawton AE; Sumner-Jones SG; Nunez-Alonso GA; Chan M; Munkonge F; Alton EW; Hyde SC; Gill DR
    Mol Ther; 2008 May; 16(5):812-8. PubMed ID: 18388934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapy in cystic fibrosis.
    Flotte TR; Laube BL
    Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Zhou ZP; Yang LL; Cao H; Chen ZR; Zhang Y; Wen XY; Hu J
    Hum Gene Ther; 2019 Sep; 30(9):1101-1116. PubMed ID: 31099266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of bacterial killing activity of human respiratory cystic fibrosis cells through cationic vector-mediated cystic fibrosis transmembrane conductance regulator gene transfer.
    Biffi A; Sersale G; Cassetti A; Villa A; Bordignon C; Assael BM; Conese M
    Hum Gene Ther; 1999 Aug; 10(12):1923-30. PubMed ID: 10466626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.